Glomerular disorder
MONDO:0019722A disease involving the renal glomerulus.
Also known as: disease of renal glomerulus, disease or disorder of renal glomerulus, disorder of renal glomerulus, glomerulopathy, renal glomerulus disease, renal glomerulus disease or disorder, glomerulopathies
481 clinical trials for this condition and its sub-types, 9 tagged with Glomerular disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Glomerular disorder
-
Glomerulonephritis 33 trials · 456 incl. sub-types
20 sub-types
- Lupus nephritis 140 trials
- IgA glomerulonephritis 123 trials
- Granulomatosis with polyangiitis 95 trials · 115 incl. sub-types Sub-types →
- Membranous glomerulonephritis 69 trials · 77 incl. sub-types Sub-types →
- Lipoid nephrosis 32 trials
- Primary membranoproliferative glomerulonephritis 0 trials · 26 incl. sub-types Sub-types →
- Membranoproliferative glomerulonephritis 11 trials
- Pauci-immune glomerulonephritis 1 trial · 5 incl. sub-types Sub-types →
- Rapidly progressive glomerulonephritis 3 trials · 4 incl. sub-types Sub-types →
- Proliferative glomerulonephritis 1 trial · 2 incl. sub-types Sub-types →
- Anti-basement membrane glomerulonephritis 1 trial
- Immunotactoid glomerulopathy 1 trial
- Acute poststreptococcal glomerulonephritis 0 trials
- Autoimmune glomerulonephritis 0 trials
- Diffuse glomerulonephritis 0 trials Sub-types →
- Exudative glomerulonephritis 0 trials
- Focal embolic glomerulonephritis 0 trials
- Immune-complex glomerulonephritis 0 trials
- Mesangial proliferative glomerulonephritis 0 trials
- Subacute glomerulonephritis 0 trials
-
Glomerulosclerosis 1 trial · 51 incl. sub-types
2 sub-types
- Focal segmental glomerulosclerosis 45 trials · 49 incl. sub-types Sub-types →
- Renal fibrosis 2 trials
-
Immunotactoid or fibrillary glomerulopathy 0 trials · 1 incl. sub-types
2 sub-types
- Immunotactoid glomerulopathy 1 trial
- Non-amyloid fibrillary glomerulopathy 1 trial
-
Collagen type III glomerulopathy 0 trials
-
Fibronectin glomerulopathy 0 trials
2 sub-types
Most studied deeper sub-types
-
New combo therapy aims to stop kidney damage in membranous nephropathy
Disease control Recruiting nowThis study tests whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely reduce protein leakage in the urine of people with membranous nephropathy, a kidney disease where the immune system attacks the kidneys. About 30 adults with persistent high pr…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for kidney disease: Zigakibart's Long-Term safety under study
Disease control Recruiting nowThis study looks at the long-term safety of a drug called zigakibart for adults with IgA nephropathy, a kidney disease. It is for people who have already finished a previous zigakibart study. Researchers will monitor side effects and check kidney function over 96 weeks.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
2000 patients join hunt for early warning signs of kidney failure
Knowledge-focused Recruiting nowThis study follows 2000 Chinese patients with IgA nephropathy who still have relatively good kidney function. Researchers will test their blood and urine for biomarkers that might predict if and when their kidney disease gets worse. No new treatment is being tested; the goal is t…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New study aims to measure swelling in kidney disease patients
Knowledge-focused Recruiting nowResearchers at the University of Michigan and Northwestern University are interviewing children, adults, and parents of young children about their experiences with swelling caused by Nephrotic Syndrome. The goal is to develop a survey that can be used in future clinical trials to…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC